Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure

References

• FinkMBolwigTGParkerGShorterEMelancholia: restoration in psychiatric classification recommendedActa Psychiatr Scand20071152899217244171
   PubMed Web of Science ®Google Scholar
• RothMUnitary or binary nature of classification of depressive illness and its implications for the scope of manic depressive disorderJ Affect Disord200164111811292515
   PubMed Web of Science ®Google Scholar
• ParkerGClassifying depression: should paradigms lost be regained?Am J Psychiatry200015781195120310910777
   PubMed Web of Science ®Google Scholar
• CaldieraroMABaezaFLPinheiroDORibeiroMRParkerGFleckMPClinical differences between melancholic and nonmelancholic depression as defined by the CORE systemCompr Psychiatry2013541111522770717
   PubMed Web of Science ®Google Scholar
• SnowdonJShould psychomotor disturbance be an essential criterion for a DSM-5 diagnosis of melancholia?BMC Psychiatry20131316023724792
   PubMed Web of Science ®Google Scholar
• ParkerGMcCrawSBlanchBHadzi-PavlovicDSynnottHReesAMDiscriminating melancholic and non-melancholic depression by prototypic clinical featuresJ Affect Disord2013144319920722868058
   PubMed Web of Science ®Google Scholar
• LamersFde JongePNolenWAIdentifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA)J Clin Psychiatry201071121582158920673552
   PubMed Web of Science ®Google Scholar
• GiliMRocaMArmengolSAsensioDGarcia-CampayoJParkerGClinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressionsPLoS One2012710e4820023110213
   PubMed Web of Science ®Google Scholar
• RothermundtMAroltVPetersMInflammatory markers in major depression and melancholiaJ Affect Disord2001631–39310211246085
   PubMed Web of Science ®Google Scholar
• RothermundtMAroltVFenkerJGutbrodtHPetersMKirchnerHDifferent immune patterns in melancholic and non-melancholic major depressionEur Arch Psychiatry Clin Neurosci20012512909711407444
   PubMed Web of Science ®Google Scholar
• KarlovicDSerrettiAVrkicNMartinacMMarcinkoDSerum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical featuresPsychiatry Res20121981748022386567
   PubMed Web of Science ®Google Scholar
• GoldPWChrousosGPMelancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depressionMol Psychiatry201318663263423698316
   PubMed Web of Science ®Google Scholar
• ParkerGFinkMShorterEIssues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorderAm J Psychiatry2010167774574720595426
   PubMed Web of Science ®Google Scholar
• ParkerGHyettMPFriendPHadzi-PavlovicDDoes age impact on rating melancholic and non-melancholic depressive symptoms?J Affect Disord20131471–331832423411026
   PubMed Web of Science ®Google Scholar
• CarrollBJFeinbergMGredenJFA specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utilityArch Gen Psychiatry198138115227458567
   PubMed Web of Science ®Google Scholar
• DavidsonJLipperSZungWWStricklandRKrishnanRMahorneySValidation of four definitions of melancholia by the dexamethasone suppression testAm J Psychiatry198414110122012236486256
   PubMed Web of Science ®Google Scholar
• LuYRFuXYShiLGDecreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorderBMC Psychiatry201414112324767108
   PubMed Web of Science ®Google Scholar
• WongMLKlingMAMunsonPJPronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormoneProc Natl Acad Sci U S A200097132533010618417
   PubMed Web of Science ®Google Scholar
• ParkerGHadzi-PavlovicDPrediction of response to antidepressant medication by a sign-based index of melancholiaAust N Z J Psychiatry199327156618481171
   PubMed Web of Science ®Google Scholar
• HickieIParsonageBParkerGPrediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology of depressionBr J Psychiatry199015765711975760
   PubMed Web of Science ®Google Scholar
• HickieIMasonCParkerGBrodatyHPrediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholiaBr J Psychiatry1996169168748818371
   PubMed Web of Science ®Google Scholar
• MolendijkMLSpinhovenPPolakMBusBAPenninxBWElzingaBMSerum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (n=9,484)Mol Psychiatry201419779180023958957
   PubMed Web of Science ®Google Scholar
• BusBAMolendijkMLPenninxBWLow serum BDNF levels in depressed patients cannot be attributed to individual depressive symptoms or symptom clusterWorld J Biol Psychiatry11132013 [Epub ahead of print]
   Web of Science ®Google Scholar
• PatasKPenninxBWBusBAAssociation between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic featuresBrain Behav Immun201436717924140302
   PubMed Web of Science ®Google Scholar
• MaesMGaleckiPChangYSBerkMA review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illnessProg Neuropsychopharmacol Biol Psychiatry201135367669220471444
   PubMed Web of Science ®Google Scholar
• LamersFVogelzangsNMerikangasKRde JongePBeekmanATPenninxBWEvidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depressionMol Psychiatry201318669269923089630
   PubMed Web of Science ®Google Scholar
• Dunjic-KosticBIvkovicMRadonjicNVMelancholic and atypical major depression – connection between cytokines, psychopathology and treatmentProg Neuropsychopharmacol Biol Psychiatry2013431623200828
   PubMed Web of Science ®Google Scholar
• MaesMScharpeSMeltzerHYRelationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depressionPsychiatry Res199349111277511248
   PubMed Web of Science ®Google Scholar
• Marques-DeakAHNetoFLDominguezWVCytokine profiles in women with different subtypes of major depressive disorderJ Psychiatr Res2007411–215215916375926
   PubMed Web of Science ®Google Scholar
• MaesMMihaylovaIKuberaMRingelKActivation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depressionProg Neuropsychopharmacol Biol Psychiatry201236116917521945535
   PubMed Web of Science ®Google Scholar
• HuangTLLeeCTT-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depressionPsychiatry Clin Neurosci200761441542017610667
   PubMed Web of Science ®Google Scholar
• LamersFVogelzangsNMerikangasKRde JongePBeekmanATPenninxBWEvidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depressionMol Psychiatry201218669269923089630
   PubMed Web of Science ®Google Scholar
• HilesSABakerALde MalmancheTAttiaJA meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneityBrain Behav Immun20122671180118822687336
   PubMed Web of Science ®Google Scholar
• KaestnerFHettichMPetersMDifferent activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activityJ Affect Disord2005872–330531115951024
   PubMed Web of Science ®Google Scholar
• SchlatterJOrtunoFCervera-EnguixSLymphocyte subsets and lymphokine production in patients with melancholic versus nonmelancholic depressionPsychiatry Res2004128325926515541783
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association DSM-5 Task ForceDiagnostic and Statistical Manual of Mental Disorders: DSM-5Arlington, VA, USAAmerican Psychiatric Association2013
   Google Scholar
• ParkerGHadzi-PavlovicDBoycePClassifying depression by mental state signsBr J Psychiatry199015755652397363
   PubMed Web of Science ®Google Scholar
• ParkerGHadzi-PavlovicDWilhelmKDefining melancholia: properties of a refined sign-based measureBr J Psychiatry199416433163268199785
   PubMed Web of Science ®Google Scholar
• ParkerGDefining melancholia: the primacy of psychomotor disturbanceActa Psychiatr Scand Suppl2007433213017280567
   PubMedGoogle Scholar
• JoycePRMulderRTLutySEMelancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant responseAust N Z J Psychiatry200236337638312060187
   PubMed Web of Science ®Google Scholar
• AttuSDRhebergenDComijsHCParkerGStekMLPsychomotor symptoms in depressed elderly patients: assessment of the construct validity of the Dutch CORE by accelerometryJ Affect Disord20121371–314615022244372
   PubMed Web of Science ®Google Scholar
• MitchellPValidity of the CORE: I A neuroendocrinological strategyParkerGHadzi-PavlovicDMelancholia: A Disorder of Movement and MoodNew York, NY, USACambridge University Press1996
   Google Scholar
• DowlatiYHerrmannNSwardfagerWA meta-analysis of cytokines in major depressionBiol Psychiatry201067544645720015486
   PubMed Web of Science ®Google Scholar
• MullerNMyintAMSchwarzMJInflammatory biomarkers and depressionNeurotox Res201119230831820658274
   PubMed Web of Science ®Google Scholar
• MillerAHMaleticVRaisonCLInflammation and its discontents: the role of cytokines in the pathophysiology of major depressionBiol Psychiatry200965973274119150053
   PubMed Web of Science ®Google Scholar
• MolendijkMLBusBASpinhovenPSerum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatmentMol Psychiatry201116111088109520856249
   PubMed Web of Science ®Google Scholar
• YoshidaTIshikawaMNiitsuTDecreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorderPLoS One201278e4267622880079
   PubMed Web of Science ®Google Scholar
• SarandolASarandolEEkerSSErdincSVatanseverEKirliSMajor depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systemsHum Psychopharmacol2007222677317299810
   PubMed Web of Science ®Google Scholar
• NgFBerkMDeanOBushAIOxidative stress in psychiatric disorders: evidence base and therapeutic implicationsInt J Neuropsychopharmacol200811685187618205981
   PubMed Web of Science ®Google Scholar
• AmorimPMini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais [validation of a short structured diagnostic psychiatric interview]Rev Bras Psiquiatr200022106115 Portuguese
   Google Scholar
• Black Dog InstituteThe CORE assessment of psychomotor change: user’s guide rating guidelines and items1996 Available from: http://www.blackdoginstitute.org.au/docs/corebooklet.pdfAccessed July 14, 2014
   Google Scholar
• ParkerGHadzi-PavlovicDHickieISub-typing depression, III. Development of a clinical algorithm for melancholia and comparison with other diagnostic measuresPsychol Med19952548338407480461
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• ZimmermanMMartinezJHFriedmanMBoerescuDAAttiullahNTobaCHow can we use depression severity to guide treatment selection when measures of depression categorize patients differently?J Clin Psychiatry201273101287129123058983
   PubMed Web of Science ®Google Scholar
• LevineRLGarlandDOliverCNDetermination of carbonyl content in oxidatively modified proteinsMethods Enzymol19901864644781978225
   PubMed Web of Science ®Google Scholar
• ShapiroSSWilkMBAn analysis of variance test for normality (complete samples)Biometrika1965523–4591611
   Web of Science ®Google Scholar
• MagalhaesPVJansenKPinheiroRTPeripheral oxidative damage in early-stage mood disorders: a nested population-based case-control studyInt J Neuropsychopharmacol20121581043105022008234
   PubMed Web of Science ®Google Scholar
• PavonLSandoval-LopezGEugenia HernandezMTh2 cytokine response in major depressive disorder patients before treatmentJ Neuroimmunol20061721–215616516457895
   PubMed Web of Science ®Google Scholar
• HernandezMEMendietaDMartinez-FongDVariations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorderEur Neuropsychopharmacol2008181291792418805677
   PubMed Web of Science ®Google Scholar
• KapczinskiFDal-PizzolFTeixeiraALPeripheral biomarkers and illness activity in bipolar disorderJ Psychiatr Res201145215616120541770
   PubMed Web of Science ®Google Scholar
• FernandesBSBerkMTurckCWSteinerJGoncalvesCADecreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysisMol Psychiatry201419775075124342989
   PubMed Web of Science ®Google Scholar
• CarrollBJGredenJFFeinbergMNeuroendocrine dysfunction in genetic subtypes of primary unipolar depressionPsychiatr Res198023251258
   Web of Science ®Google Scholar
• CalcagniEElenkovIStress system activity, innate and T helper cytokines, and susceptibility to immune-related diseasesAnn N Y Acad Sci20061069627616855135
   PubMed Web of Science ®Google Scholar
• Dalle-DonneIRossiRGiustariniDMilzaniAColomboRProtein carbonyl groups as biomarkers of oxidative stressClin Chim Acta20033291–2233812589963
   PubMed Web of Science ®Google Scholar
• StefanescuCCiobicaAThe relevance of oxidative stress status in first episode and recurrent depressionJ Affect Disord20121431–3343822840610
   PubMed Web of Science ®Google Scholar
• BiliciMEfeHKorogluMAUyduHABekarogluMDegerOAntioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatmentsJ Affect Disord2001641435111292519
   PubMed Web of Science ®Google Scholar
• PapandreouCSchizaSETzatzarakisMNEffect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trialSleep Breath201216387387921918812
   PubMed Web of Science ®Google Scholar
• HickieIHickieCLloydASiloveDWakefieldDImpaired in vivo immune responses in patients with melancholiaBr J Psychiatry19931626516578149117
   PubMed Web of Science ®Google Scholar
• StetlerCMillerGEDepression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of researchPsychosom Med201173211412621257974
   PubMed Web of Science ®Google Scholar
• ParkerGBrotchieHMajor depression invites major concernsRev Bras Psiquiatr200931Suppl 1S3S6 Portuguese19565149
   PubMedGoogle Scholar
• SutcigilLOktenliCMusabakUPro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapyClin Dev Immunol200720077639618317531
   PubMed Web of Science ®Google Scholar
• JedingIEvansPJAkanmuDCharacterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugsBiochem Pharmacol19954933593657857323
   PubMed Web of Science ®Google Scholar
• HuangCJFwuMLDegree of protein deficiency affects the extent of the depression of the antioxidative enzyme activities and the enhancement of tissue lipid peroxidation in ratsJ Nutr199312358038108487090
   PubMed Web of Science ®Google Scholar
• CubedduABucciFGianniniABrain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndromePsychoneuroendocrinology201136452353020933336
   PubMed Web of Science ®Google Scholar